Health / Medical Topics

    TS Hauschka, Fox Chase Ha:ICR

    This random bred stock was developed at the Institute for Cancer Research (Fox Chase Cancer Center) by Dr. T.S. Hauschka beginning in 1948. Dr. Hauschka developed the high production and high growth rate characteristics of the Icr:Ha(ICR) stock by rigid selection over a period of several years. When he left the Institute for Cancer Research in 1954, Dr. Hauschka took part of his HA(ICR) colony with him to Roswell Park Memorial Institute in Buffalo, N.Y. The remainder of the colony was left at Fox Chase where a modified version of Robertson's mating system has been used to minimize the rate of inbreeding. In agreement with Dr. Hauschka, Fox Chase designates its random bred stock "Icr:Ha(ICR)" to differentiate it from Dr. Hauschka's stock since the two colonies probably began to drift apart genetically very shortly after August, 1959. (from taconic.com) (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Tryptophan 5-hydroxylase 1 (444 aa, ~51 kDa) is encoded by the human TPH1 gene. This protein plays a role in the metabolism…
    Tryptophan 2,3-dioxygenase (406 aa, ~48 kDa) is encoded by the human TDO2 gene. This protein is involved in the metabolism of tryptophan…
    The least plentiful of all 22 amino acids and an essential amino acid in humans (provided by food), Tryptophan is found in…
    A technique for proteolysis of proteins into peptides at lysine or arginine by treatment with the pancreatic enzyme trypsin.
    The determination of the amount of tryptase present in a sample.
    An arsenic compound with activity against Spirochaetes bacteria. Tryparsamide is used in the treatment of syphilis and African sleeping sickness.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact